Marriott's Residence Inn to double Europe portfolio

Residence Inn London – Kensington

Marriott International is expanding its extended-stay brand, Residence Inn by Marriott, with the signing of two new properties in London. With additional openings in Amsterdam and Aberdeen this year, Residence Inn expects to more than double its European portfolio in 2017.

The opening of Residence Inn London – London Bridge (expected in the second quarter of 2017) will mark the debut of the company’s extended-stay brand in the capital, and the opening of Residence Inn London – Kensington is scheduled to follow in the fourth quarter.

Both properties, owned by a controlled affiliate of Starwood Capital Group, will be operated under a franchise agreement with Cycas Hospitality—London’s second-largest operator of serviced apartment and apart-hotels.

Virtual Roundtable

Post COVID-19: The New Guest Experience

Join Hotel Management’s Elaine Simon for our latest roundtable—Post COVID-19: The New Guest Experience. The experts on the panel will share how to inspire guest confidence that hotels are safe and clean and how to win back guest business.

“We see these latest signings as a fantastic opportunity to grow the brand in such a strategic global destination, and we’re excited to be working with Cycas Hospitality, which has a strong history of hospitality expertise,” Carlton Ervin, CDO Europe at Marriott International, said in a statement.

The two London properties will be joined by new openings expected in Aberdeen and Amsterdam, growing the European portfolio from three to seven hotels. The four additions planned for 2017 will see almost 600 rooms added to the Residence Inn portfolio, and there are a further eight properties anticipated by the end of 2019.

Suggested Articles

Insurance companies believe that COVID-19-related losses should not be included in business interruption coverage, but the issue is far from settled.

The MMGY Global Travel Safety Barometer measures Americans’ perceptions of safety on a scale from 0 (extremely unsafe) to 100 (extremely safe).

The cards contain patented New Antimicrobial Layer technology to inhibit the growth and transmission of germs, viruses and pathogens.